Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Bacterial Conjunctivitis - Overview
Bacterial Conjunctivitis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Bacterial Conjunctivitis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Bacterial Conjunctivitis - Companies Involved in Therapeutics Development
Cellics Therapeutics Inc
Kurobe LLC
Laboratorios Sophia SA de CV
Takeda Pharmaceutical Co Ltd
TGV-Inhalonix Inc
Bacterial Conjunctivitis - Drug Profiles
CTI-005 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
levofloxacin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Mul-1867 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pazufloxacin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SHP-640 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
vancomycin hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Bacterial Conjunctivitis - Dormant Projects
Bacterial Conjunctivitis - Product Development Milestones
Featured News & Press Releases
Oct 03, 2013: Lupin launches Generic ZYMAXID Ophthalmic solution in the US
Aug 28, 2013: Lupin Receives FDA Approval For Gatifloxacin Eye Drops
Jul 01, 2013: Lupin Gets FDA Tentative Approval For Gatifloxacin Eye Drops
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Bacterial Conjunctivitis, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Targets, H2 2020
Number of Products by Stage and Targets, H2 2020
Number of Products by Mechanism of Actions, H2 2020
Number of Products by Stage and Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development for Bacterial Conjunctivitis, H2 2020
Number of Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Bacterial Conjunctivitis - Pipeline by Cellics Therapeutics Inc, H2 2020
Bacterial Conjunctivitis - Pipeline by Kurobe LLC, H2 2020
Bacterial Conjunctivitis - Pipeline by Laboratorios Sophia SA de CV, H2 2020
Bacterial Conjunctivitis - Pipeline by Takeda Pharmaceutical Co Ltd, H2 2020
Bacterial Conjunctivitis - Pipeline by TGV-Inhalonix Inc, H2 2020
Bacterial Conjunctivitis - Dormant Projects, H2 2020